DK1178982T3 - Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet - Google Patents

Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet

Info

Publication number
DK1178982T3
DK1178982T3 DK00932445T DK00932445T DK1178982T3 DK 1178982 T3 DK1178982 T3 DK 1178982T3 DK 00932445 T DK00932445 T DK 00932445T DK 00932445 T DK00932445 T DK 00932445T DK 1178982 T3 DK1178982 T3 DK 1178982T3
Authority
DK
Denmark
Prior art keywords
agents
nervous system
central nervous
heterocyclic substituted
compounds useful
Prior art date
Application number
DK00932445T
Other languages
Danish (da)
English (en)
Inventor
Jerome F Daanen
Kevin B Sippy
Keith B Ryther
Jianguo Ji
Michael R Schrimpf
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/559,881 external-priority patent/US6833370B1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1178982T3 publication Critical patent/DK1178982T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00932445T 1999-05-21 2000-05-15 Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet DK1178982T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31670799A 1999-05-21 1999-05-21
US09/559,881 US6833370B1 (en) 1999-05-21 2000-04-26 Heterocycle substituted aminoazacycles useful as central nervous system agents
PCT/US2000/013339 WO2000071534A1 (fr) 1999-05-21 2000-05-15 Aminoazacycles heterocylcliques substitues utiles en tant qu'agents actifs sur le systeme nerveux central
EP00932445A EP1178982B1 (fr) 1999-05-21 2000-05-15 Aminoazacycles heterocylcliques substitues utiles en tant qu'agents actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
DK1178982T3 true DK1178982T3 (da) 2004-11-08

Family

ID=26980553

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00932445T DK1178982T3 (da) 1999-05-21 2000-05-15 Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet

Country Status (24)

Country Link
EP (2) EP1428824A1 (fr)
JP (1) JP2003500402A (fr)
KR (2) KR100714122B1 (fr)
CN (2) CN1636990A (fr)
AT (1) ATE270288T1 (fr)
AU (1) AU781241B2 (fr)
BG (1) BG106192A (fr)
BR (1) BR0007229A (fr)
CA (1) CA2373793A1 (fr)
CZ (1) CZ20014127A3 (fr)
DE (1) DE60011895T2 (fr)
DK (1) DK1178982T3 (fr)
ES (1) ES2226844T3 (fr)
HK (1) HK1045305B (fr)
HU (1) HU225894B1 (fr)
IL (2) IL146476A0 (fr)
MX (1) MXPA01011897A (fr)
NO (1) NO20015669L (fr)
NZ (1) NZ515207A (fr)
PL (1) PL200427B1 (fr)
PT (1) PT1178982E (fr)
SI (1) SI1178982T1 (fr)
SK (1) SK16812001A3 (fr)
WO (1) WO2000071534A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
MY137020A (en) * 2000-04-27 2008-12-31 Abbott Lab Diazabicyclic central nervous system active agents
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
US20040242641A1 (en) * 2003-05-27 2004-12-02 Buckley Michael J. (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US7399765B2 (en) 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
UY30846A1 (es) 2006-12-30 2008-07-31 Abbott Gmbh & Amp Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
JP5701607B2 (ja) 2007-12-07 2015-04-15 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー アミドメチル置換オキシインドール誘導体およびバソプレッシン依存性疾患の治療へのこれらの使用
MX2010006204A (es) 2007-12-07 2011-03-16 Abbott Gmbh & Co Kg Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
WO2010009775A1 (fr) 2007-12-07 2010-01-28 Abbott Gmbh & Co. Kg Dérivés d'oxindole à substitution carbamate et utilisation de ceux-ci pour traiter des maladies dépendant de la vasopressine
NZ586651A (en) 2007-12-07 2012-06-29 Abbott Gmbh & Co Kg 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
US20100331546A1 (en) * 2008-02-27 2010-12-30 Sumitomo Chemical Company, Limited Method for optical resolution of alkyl piperidin-3-yl carbamate and intermediate therefor
JP2009256298A (ja) * 2008-03-26 2009-11-05 Sumitomo Chemical Co Ltd ピペリジン−３−イルカーバメート化合物の光学分割方法およびその中間体
US9463190B2 (en) 2008-03-31 2016-10-11 University Of South Florida Methods of treating disease-induced ataxia and non-ataxic imbalance
WO2009149135A1 (fr) 2008-06-04 2009-12-10 Abbott Laboratories Isoxazoles substitués de bis (hétéro) aryle pour utilisation comme modulateurs de récepteurs nicotiniques neuronaux
TW201022233A (en) * 2008-11-04 2010-06-16 Organon Nv (Pyrrolidin-2-yl)phenyl derivatives
EP2435080A2 (fr) 2009-05-29 2012-04-04 Abbott Laboratories Compositions pharmaceutiques utilisées dans le traitement de la douleur
WO2010151815A2 (fr) 2009-06-25 2010-12-29 Abbott Laboratories Amines et urées 3,9-diazaspiro[5,5]undécane et procédés d'utilisation correspondants
AR077688A1 (es) 2009-08-04 2011-09-14 Takeda Pharmaceutical Compuestos heterociclicos, utiles en el tratamiento de cancer
CN102936220B (zh) * 2012-11-15 2014-07-02 河北桑迪亚医药技术有限责任公司 一种氨基吡啶boc保护的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302456A (en) 1977-04-13 1981-11-24 The Upjohn Company Process for therapeutic treatment
FR2459240A1 (fr) * 1979-06-21 1981-01-09 Cm Ind Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
EP0647639A1 (fr) * 1993-10-11 1995-04-12 Sanofi Hétéroarylpipéridines, procédé pour leur préparation et compositions pharmaceutiques les contenant
CA2133855A1 (fr) * 1993-10-11 1995-04-12 Marco Baroni Heteroarylpiperidines, leur mode de preparation et compositions pharmaceutiques qui en contiennent
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors

Also Published As

Publication number Publication date
DE60011895D1 (de) 2004-08-05
HUP0202034A3 (en) 2006-04-28
PL200427B1 (pl) 2009-01-30
HU225894B1 (en) 2007-12-28
CN1361774A (zh) 2002-07-31
SI1178982T1 (en) 2004-12-31
BR0007229A (pt) 2002-09-10
HK1045305B (zh) 2005-04-01
DE60011895T2 (de) 2005-08-04
BG106192A (bg) 2002-08-30
AU5016600A (en) 2000-12-12
CN1192028C (zh) 2005-03-09
JP2003500402A (ja) 2003-01-07
ES2226844T3 (es) 2005-04-01
ATE270288T1 (de) 2004-07-15
NO20015669L (no) 2001-11-23
EP1178982A1 (fr) 2002-02-13
IL146476A0 (en) 2002-07-25
CN1636990A (zh) 2005-07-13
KR100714122B1 (ko) 2007-05-04
KR20060110877A (ko) 2006-10-25
EP1178982B1 (fr) 2004-06-30
IL190780A0 (en) 2008-11-03
AU781241B2 (en) 2005-05-12
CZ20014127A3 (cs) 2002-06-12
PL352066A1 (en) 2003-07-28
HUP0202034A2 (en) 2002-10-28
KR100714121B1 (ko) 2007-05-04
CA2373793A1 (fr) 2000-11-30
MXPA01011897A (es) 2002-06-21
WO2000071534A1 (fr) 2000-11-30
SK16812001A3 (sk) 2002-05-09
EP1428824A1 (fr) 2004-06-16
NO20015669D0 (no) 2001-11-20
HK1045305A1 (en) 2002-11-22
PT1178982E (pt) 2004-11-30
KR20060118618A (ko) 2006-11-23
NZ515207A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
DK1178982T3 (da) Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
ES2166954T3 (es) Derivados de 1-fenilpirazol y su uso como agentes parasiticidas.
NO20063132L (no) Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
NO953305L (no) Antranilsyrederivat
BR0013041A (pt) Composto heterociclico e composição farmacêutica para tratar e prevenir doenças mediadas por cgmp-pde, seu uso e método
DE60129712D1 (de) Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
NO20042024L (no) 4-(4-alkoksy-3-hydroksyfenyl)-2-pyrrolidonderivater som PDE4-inhibitorer for behandling av nevrologiske syndromer
ATE370735T1 (de) Phenylpyridazinderivate und diese enthaltende arzneimittel
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
CO5080802A1 (es) Nuevos compuestos heterociclicos inhibidores de la fosfodiesteresa iv y su formulacion y uso como productos farmaceuticos
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
EP1211253A4 (fr) Derives dihydrobenzofuran tricycliques, leur procede de preparation et agents
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
DK1072601T3 (da) 4-Arylpiperidinderivater til behandling af pruritus
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
DK0421668T3 (da) 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr
DE69018741D1 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.